Back

Amyloid: CMR is king.

8 May 2021 (11:00 - 11:10)
Organised by:
Congress Presentation Part of: Cardiovascular magnetic resonance vs nuclear in amyloidosis and inflammation Epidemiology, Prognosis, Outcome EACVI Premium Access EuroCMR 2021

About the speaker

Photo
Professor Marianna Fontana

University College London, London (United Kingdom of Great Britain & Northern Ireland)

4 More presentations in this session

Presentation thumbnail
Sarcoidosis: positron emission tomography (PET) is king.
Doctor S. Dorbala (Boston, US)
Slides Video
Presentation thumbnail
Sarcoidosis: CMR is king.
Doctor A. Patel (Charlottesville, US)
Slides Video
Presentation thumbnail
Amyloid: nuclear is king.
Doctor A. Gimelli (Pisa, IT)
Slides Video
Presentation thumbnail
Cardiovascular magnetic resonance vs nuclear in amyloidosis and inflammation - discussion.

Access the full session

Session thumbnail
Cardiovascular magnetic resonance vs nuclear in amyloidosis and inflammation
Video

The Event

Event poster

EuroCMR 2021

8 May 2021 11:00 CET
You may be interested in
thumbnail
Webinar
Cardiac MR in the management of heart failure patients
21 March 2022
thumbnail
Congress Presentation
Prognostic impact of left atrial function in patients with cardiac amyloidosis: a cardiac magnetic resonance study
1 September 2019
thumbnail
Congress Presentation
Monitoring amyloidosis treatment
30 August 2025
thumbnail
Webinar
Cardiac amyloidosis in valvular heart disease
29 September 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources